From: The immunological function of CXCR2 in the liver during sepsis
Target
Drugs
Current status
Clinical Trials Identifier
CXCL8
Antibodies
HuMax-IL8
Malignant solid tumor [157]
NCT02536469
CXCR2
Small molecular inhibitors
Reparixin
IRI of liver transplant [158]; tumor [159]
NCT03031470;
NCT02370238;
Danirixin
COPD [160]; viral disease [161]
NCT03034967;
NCT02469298